BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 38164270)

  • 1. Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research.
    Ceci C; García-Chico C; Atzori MG; Lacal PM; Lista S; Santos-Lozano A; Graziani G; Pinto-Fraga J
    J Cancer; 2024; 15(1):1-19. PubMed ID: 38164270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review.
    García-Chico C; López-Ortiz S; Peñín-Grandes S; Pinto-Fraga J; Valenzuela PL; Emanuele E; Ceci C; Graziani G; Fiuza-Luces C; Lista S; Lucia A; Santos-Lozano A
    Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experience of outdoor physical activity for skin cancer survivors: understanding the importance of the built and natural environments.
    Tabatabaie S; Litt JS; Crane LA
    J Cancer Surviv; 2020 Oct; 14(5):739-756. PubMed ID: 32506221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The consequences for human health of stratospheric ozone depletion in association with other environmental factors.
    Lucas RM; Norval M; Neale RE; Young AR; de Gruijl FR; Takizawa Y; van der Leun JC
    Photochem Photobiol Sci; 2015 Jan; 14(1):53-87. PubMed ID: 25383760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between occupational sun exposure and non-melanoma skin cancer: clinical basics, epidemiology, occupational disease evaluation, and prevention.
    Fartasch M; Diepgen TL; Schmitt J; Drexler H
    Dtsch Arztebl Int; 2012 Oct; 109(43):715-20. PubMed ID: 23181135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.
    Bonfill-Teixidor E; Iurlaro R; Handl C; Wichmann J; Arias A; Cuartas I; Emmenegger J; Romagnani A; Mangano L; Lorber T; Berrera M; Godfried Sie C; Köchl F; Eckmann J; Feddersen R; Kornacker M; Schnetzler G; Cicuendez M; Cordero E; Topczewski TE; Ferres-Pijoan A; González J; Martínez-Ricarte F; Muñoz-Couselo E; Tabernero J; Bischoff JR; Pettazzoni P; Seoane J
    Cancer Res; 2022 Jul; 82(14):2552-2564. PubMed ID: 35584009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human health effects of ozone depletion and interactions with climate change.
    Norval M; Lucas RM; Cullen AP; de Gruijl FR; Longstreth J; Takizawa Y; van der Leun JC
    Photochem Photobiol Sci; 2011 Feb; 10(2):199-225. PubMed ID: 21253670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous BRAF(V600E) and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity.
    Gadiot J; Hooijkaas AI; Deken MA; Blank CU
    Onco Targets Ther; 2013; 6():1649-58. PubMed ID: 24348046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Athletes Practicing Outdoors Know and Care Enough About the Importance of Photoprotection?
    Buljan M; Kolić M; Šitum M; Šekerija M; Franceschi N
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):41-42. PubMed ID: 32650851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.
    Kuske M; Westphal D; Wehner R; Schmitz M; Beissert S; Praetorius C; Meier F
    Pharmacol Res; 2018 Oct; 136():151-159. PubMed ID: 30145328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection-adjusted UV dose estimated for body areas: Daily self-reported sun protection modification of wearable UV sensor dose.
    Robinson JK; Durst DA; Gray E; Kwasny M
    Photodermatol Photoimmunol Photomed; 2020 Sep; 36(5):357-364. PubMed ID: 32189399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity, cardiorespiratory fitness and risk of cutaneous malignant melanoma: Systematic review and meta-analysis.
    Behrens G; Niedermaier T; Berneburg M; Schmid D; Leitzmann MF
    PLoS One; 2018; 13(10):e0206087. PubMed ID: 30379884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition.
    Jiang X; Zhou J; Giobbie-Hurder A; Wargo J; Hodi FS
    Clin Cancer Res; 2013 Feb; 19(3):598-609. PubMed ID: 23095323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review.
    Lopes FCPS; Sleiman MG; Sebastian K; Bogucka R; Jacobs EA; Adamson AS
    JAMA Dermatol; 2021 Feb; 157(2):213-219. PubMed ID: 33325988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis.
    Erkes DA; Cai W; Sanchez IM; Purwin TJ; Rogers C; Field CO; Berger AC; Hartsough EJ; Rodeck U; Alnemri ES; Aplin AE
    Cancer Discov; 2020 Feb; 10(2):254-269. PubMed ID: 31796433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge about Ultraviolet Radiation Hazards and Tanning Behavior of Cosmetology and Medical Students.
    Zuba EB; Francuzik W; Malicki P; Osmola-Mańkowska A; Jenerowicz D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):73-7. PubMed ID: 27149135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.